NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dr. Reddy’s Laboratories Limited (“Dr. Reddy’s” or the “Company”) (NYSE: RDY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
ONLY AVAILABLE IN PAID PLANSCanada Pension Plan Investment Board acquired a new position in Royal Bank Of Canada (NYSE:RY - Free Report) (TSE:RY) during the 2nd quarter, according to the…
It was confirmed on Tuesday that the country singer had passed away at the age of 80.
The Trump administration plans to revoke the visas of foreign nationals who entered the US as short-term visitors and later applied for asylum. “Obtaining a vi…
NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Taboola.com Ltd. (“Taboola” or the “Comp…
Immigration and Customs Enforcement agents walk outside the Ventura County Government Center in Ventura, Calif., on July 27, 2026. (Blake Fagan/AFP via Getty I…
Five women-led dairy companies in UP generate ₹5,716 crore turnover, collecting 12.5L litres daily from 3.88 lakh rural women across 31 districts.